In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is moving to an online platform or postponing all meetings and events intended to be held in person through April 30, 2020. Please check here for more information, including Academy programs on COVID-19, and links to the latest advisories from public health officials.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Ken Shatzkes

Ken Shatzkes, Ph.D.

Senior Program Officer

Foundation for Opioid Response Efforts (FORE)

Dr. Shatzkes is the Senior Program Officer at FORE and helps to identify innovative, patient-centered, evidence-based solutions addressing the nation’s opioid crisis. He studied Molecular Genetics and Development at McGill University before moving to Rutgers, The State University of New Jersey to complete his Ph.D. in Immunology and Infectious Disease. Dr. Shatzkes has over 15 years of experience performing biomedical research at institutions such as NYU Langone Medical Center, the J. Craig Venter Institute, and the U.S. FDA. He has worked on NIH-, DoD-, DHS-, and DARPA-funded research projects, including developing innovative detection methods of bio-threat microorganisms, large-scale genomic studies of antibiotic resistant bacteria, and using predatory bacteria as a novel antimicrobial. In addition, Dr. Shatzkes has advised federal and state political leadership on a range public health issues, from infectious disease to the opioid crisis. In 2017, he served as the Science Policy Advisor to the Governor of New Jersey.